Medicine: What you need to know about “Biosimilars”

Podcast
News from the World of Medicine
  • 2017 01 Medicine, Biosimilars
    29:25
audio
29:25 Min.
Medicine: Mediterranean diet
audio
29:25 Min.
Medicine: Corticosteroids for asthma
audio
29:25 Min.
Medicine: Away from aspirin?
audio
29:25 Min.
Medicine: Mild hypertension during pregnancy
audio
29:25 Min.
Medicine: CT coronary angiography
audio
29:25 Min.
Medicine: Vitamin D supplements do not work
audio
29:25 Min.
Medicine: Covid-19 in the year 2022
audio
29:25 Min.
Medicine: Treatment of outpatients with Covid-19
audio
29:25 Min.
Medicine: i.v. contrast media in kidney disease
audio
29:25 Min.
Medicine: Use of platelet-rich plasma

Monoclonal antibodies are used in medicine mostly (but not exclusively) for the treatment of cancer.
Biosimilars are copies of monoclonal antibodies.
The approval process for biosimilars in Europe is unusually strict. Much stricter than the approval process for other generic drugs.
You do not need to worry about biosimilars.
Biosimilars achieve the same clinical result as those that have been achieved already with the initial original drug.
And in Europe, biosimilars are about 50% cheaper than the original drugs, and these original drugs have very high prices.

Dokumente

2017 01 Medicine, Biosimilars, PDF, 426.0 kB Download

Schreibe einen Kommentar